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Abstract. This study was designed to examine whether 
macula densa function is involved in the changes of re- 
nal renin gene expression upon acute hypoperfusion of
one kidney. To block macula densa function, rats with 
free access to salt and water were subcutaneously in-
fused with furosemide (12 mg/day) for 6 days. Then, 
4 days after the start of the infusion, the left renal arte- 
ries were clipped with 0.2-ram silver clips and renin 
mRNA levels in ipsilateral and contralateral kidneys, as 
well as plasma renin activities (PRA), were determined 
48 h after clipping. In non-clipped animals furosemide 
increased PRA from 10 to 47 ng angiotensin I 9 h -1 9 ml 1 
and raised renin mRNA levels in both kidneys 2.5-fold. 
In vehicle-infused animals, clipping of the left renal ar- 
tery increased PRA to 37 ng angiotensin I . h - l .  m1-1 
and led to a 5-fold rise of renin mRNA levels in the 
ipsilateral kidneys and to a suppression to 20% of the 
control values in the contralateral kidneys. PRA values 
in clipped and furosemide-infused animals were 45 ng 
angiotensin I. h 1. ml-'. In these animals renin mRNA 
levels increased in the ipsilateral kidneys to similar ab- 
solute values as in vehicle-infused rats, whilst contralat- 
eral renin mRNA levels fell to about 25% of the respec- 
tive controls. These findings indicate that the stimula- 
tions of renin gene expression by inhibition of macula 
densa salt transport and by renal artery clipping are not 
additive, suggesting that the macula densa mechanism 
may participate in the stimulation of renin gene ex- 
pression upon hypoperfusion. The macula densa mecha- 
nism, however, appears to be not essentially involved in 
the suppression of renin gene expression i the contralat- 
erals to stenosed kidneys. 
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Introduction 
There is increasing evidence that acute and chronic hy- 
poperfusion of one kidney causes characteristic changes 
not only of the renin content (for review [22]), but also 
of the levels of renin mRNA, in such a way that renin 
mRNA levels increase ipsilaterally and decrease contra- 
laterally [13, 15, 19]. Since the regulation of the renin 
gene at the cellular level is in general only poorly under- 
stood, the mechanisms responsible for this differential 
regulation of renin gene expression in the kidneys in 
beings with unilateral renal artery stenosis have not yet 
been elucidated. In particular, it is unknown how much 
the macula densa mechanism is involved in this process. 
Meanwhile it has been well established that the macula 
densa exerts a negative control function on renin se- 
cretion [9, 11, 20] and further evidence suggests that the 
macula densa function participates in the control of renin 
secretion by the renal perfusion pressure [20]. There is 
accumulating evidence that inhibition of macula densa 
function by loop diuretics uch as furosemide not only 
stimulate renin secretion but also renin gene expression 
[1, 3, 6, 12] even in salt-balanced rats [14]. These find- 
ings prompted us to examine a possible participation of 
the macula densa mechanism in the change of renal re- 
nin gene expression upon unilateral renal artery stenosis 
for the following reasons. 
Hypoperfusion of a kidney below the autoregulatory 
range of glomerular filtration will decrease the delivery 
of NaC1 to the macula densa nd thus inactivate the mac- 
ula densa mechanism and could therefore increase renin 
gene expression. A compensatory increase of glomerular 
filtration in the contralateral kidney [17], on the other 
hand, could activate the macula densa mechanism and 
thus contribute to the suppression of renin mRNA levels 
in this organ. 
It appeared reasonable to us, therefore to examine a
possible involvement of the macula densa in this con- 
text. As an experimental model with inhibited macula 
densa salt transport we used rats that were chronically 
infused with furosemide and that had free access to salt 
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and water. This manoeuvre has recently been demon- 
strated to balance salt and water losses and thus to main- 
tain a normal  b lood pressure and sodium balance [8]. 
Uni lateral  renal hypoperfus ion was induced by c l ipping 
one renal artery ( two-k idney/one-c l ip  model).  As an esti- 
mate for renin gene expression renin mRNA levels were 
measured by an RNase protect ion assay. 
The results obtained suggest that the macula densa 
mechanism is l ikely to be involved in the enhancement 
of  renin gene expression in the stenosed kidney, but not 
in the suppression of  renin gene expression in the contra- 
lateral kidney. 
Materials and methods 
Animals. Male Wistar rats (n = 20, Charles River Wiga, Sulzfeld, 
Germany) weighing 140-160 g were kept in metabolic ages. 
They were fed standard chow and two bottles of drinking solution 
were equally available, one containing tap water, the other a salt 
solution of 0.8% NaC1 and 0.1% KC1. Body weight, drinking input 
and urinary output were measured every day. For the first 4 days 
of the experiment all animals were kept under the same conditions. 
Then osmotic pumps (2 ML1; Alzet, Palo Alto, USA) were im- 
planted in the neck subcutaneously (day 0). In ten control animals 
the pumps were filled with 0.9% NaC1, in ten furosemide-treated 
animals with 2 ml diacetadozol (Dimazon; Hoechst, Frankfurt, 
Germany) equivalent to 50 mg/ml furosemide. The delivery rate 
of the pumps was t0 ~tl/h, thus the daily dosage of furosemide was 
12 mg per animal. The capacity of the pumps had been designed 
for 7 days. To guarantee a constant drug effect during the experi- 
ment, the pumps were primed in vitro for at least 4 h before im- 
plantation. Then, 4 days after implantation of the pumps (day 4) 
animals were anaesthetized with methohexital (50 mg/kg) and the 
left kidney was exposed by an abdominal incision. In five furosem- 
ide and in five vehicle-treated animals, sterile silver clips (De- 
gussa, Germany) with an inner diameter of 0.2 mm were then 
placed on the left renal artery, in the other five furosemide and 
vehicle-treated animals kidneys were touched only with a forceps 
(sham clipped). After the operation, animals were awakened within 
a few minutes from narcosis. Then, 48 h after application of the 
clips (day 6) animals were killed by decapitation, because in pre- 
vious experiments (Schricker et al., submitted) we found a maxi- 
mal increase of renin mRNA levels 48 h after setting the clips. 
During the time of the experiment systolic blood pressure was 
measured with a BP recorder (Rhema, Hofheim, Germany) on day 
0 (before implantation of the osmotic pump), on day 4 (before 
clipping of the left renal artery) and on day 6, 
Processing of the kidneys. Five animals of each group were pro- 
cessed for determination f plasma renin activity (PRA) and assay 
of renal renin mRNA. To this end animals were sacrificed by de- 
capitation and blood was collected from the carotid arteries for 
determination f PRA and plasma sodium concentration a d both 
kidneys were rapidly removed, weighed, cut in half and frozen in 
liquid nitrogen for extraction of total RNA. 
Determination of preplvrenin mRNA. Total RNA was extracted 
from the fight kidneys which were stored at -70~ according to 
the protocol by Chomczynski et al. [4] by homogenization in 10 ml 
of solution D [4 mM guanidine thiocyanate, containing 0.5% N- 
lauryl-sarcosinate, 10mM ethylenediaminetetraacetate (EDTA), 
25 mM sodium citrate, 700 mM fl-mercaptoethanol] with a poly- 
tron homogenizer. Sequentially, t ml of 2 M sodium acetate 
(pH 4), 10 ml of phenol (water saturated) and 2 ml of chloroform 
were added to the homogenate, with thorough mixing after ad- 
dition of each reagent. After cooling on ice for 15 rain samples 
were centrifuged at 10,000 g for 15 rain at 4~ RNA in the super- 
natant was precipitated with an equal volume of isopropanol at 
-20~ for at least 1 h. After centrifugation RNA pellets were 
resuspended in 0.5 ml of solution D, again precipitated with an 
equal volume of isopropanol at -20~ and RNA pellets finally 
dissolved in diethylpyrocarbonate water and stored at -80~ till 
further processing. Renin mRNA was measured by RNase protec- 
tion as described for erythropoietin [18]. A preprorenin cRNA 
probe containing 296 base pairs of exon I and II, generated from 
a pSP64 vector carrying a PstI-KpnI restriction fragment of a rat 
prepronin cDNA [2] was generated by transcription with SP6 RNA 
polymerase (Amersham, Amersham, UK). Transcripts were con- 
tinuously labelled with [a3ap]GTP (where GTP is guanosine 
triphosphate, 1,5 • t0 ~3 Bq/mmol or 410 Ci/mmol; Amersham) 
and purified on a Sephadex G50 spun column. For hybridization 
total kidney RNA was dissolved in a buffer containing 80% 
formamide, 40 mM piperazine-N,N'-bis(2-ethane sulphonic acid), 
400 mM NaC1, t mM EDTA (pH 8). Then, 20 gg RNA were hy- 
bridized in a total volume of 50 gl at 60~ for 12 h with 8.3 kBq 
(5• 105 cpm) radiolabelled renin probe. RNase digestion with 
RNase A and Tt was carried out at 20~ for 30 min and termin- 
ated by incubation with proteinase K (0.1 mg/ml) and sodium do- 
decylsulphate (0.4%) at 37~ for 30 rain. Protected renin mRNA 
fragments were purified by phenol/chloroform extraction, ethanol 
precipitation and subsequent electrophoresis on a denaturing 10% 
polyacrylamide gel. After autoradiography of the dried gel at 
-70~ for 1 -2  days bands representing protected renin mRNA 
fragments were excised from the gel and radioactivity was counted 
with a liquid scintillation counter (1500 Tri-CarbTm, Packard In- 
strument Company, Downers Grove, IU., USA). The number of 
counts per minute obtained from each sample of total kidney RNA 
was expressed relative to an external renin mRNA standard in- 
cluded in each hybridization, consisting of 20 gg pooled RNA ex- 
tracted from the 12 kidneys of six normal Sprague Dawley rats. 
Determination of actin mRNA. The abundance of rat cytoplasmatic 
fl-actin mRNA in total RNA isolated from the kidneys was deter- 
mined by RNase protection assay exactly as described for prepro- 
renin. An actin cRNA probe containing the 76 nucleotide first 
exon and around 200 base pairs of the surrounding sequence was 
generated by transcription with SP6 polymerase from a pAMt9 
vector carrying a AvaI/HindII1 restriction fragment of actin cDNA 
[18]. For one assay 2.5 gg RNA were hybridized under the con- 
ditions described for the determination f renin mRNA. 
Plasma renin activity (PRA). This was determined utilizing a com- 
mercially available radioimmunoassay kit for angiotensin I (Sorin 
Biomedica, Dtisseldorf, Germany). 
Determination of plasma sodium concentration. Plasma sodium 
concentration was measured by flame photometry (Flame pho- 
tometer, Eppendorf, Hamburg, Germany). 
Statistics. ANOVA test was used for interindividual comparisons 
and Student's paired t-test for intraindividual comparisons. 
P < 0.05 was considered significant. 
Results 
Chronic subcutaneous infusion of  furosemide increased 
urine output in the animals from 8 to 47 ml/day (Ta- 
ble 1). K idney masses increased sl ightly during furosem- 
ide infusion (Table 1). To avoid salt and water loss and 
in consequence volume contraction, the rats had free ac- 
cess to chow, salt water (0.9% NaC1, 0.1% KC1) and 
water. Neither p lasma sodium concentrat ion or b lood 
pressure were changed in furosemide-treated animals 
(Table 1, Fig. 1, upper panel), which increased their 
body weights by 25.2 _+ 3.5 g during the 6 days of  furo- 
semide infusion. Cl ipping the left renal arteries with 0.2- 
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Table 1. Effect of furosemide (12 mg/day) on urine output, plasma 
sodium concentration, body weight gain and kidney masses 
Variable Group 
Control Furosemide 
Urine output 8.3 + 2.7 
(ml/day) 
Plasma sodium 144 _+ 4 
concentration 
(nmol/1) 
Body weight gain 54 _+ 5.8 
(g/6 day) 
Kidney masses 
(rag) 
46.9 _+ 8.0* 
150 + 3 
25.2 + 3.5* 
R L R L 
1037 1007 1195 1185" 
+ 75 _+ 62 -+ 38 _+ 35 
Data are expressed as means _+ SEM of five animals in each exper- 
imental group. * P < 0.05 vs vehicle-treated animals. R, Right; L, 
Left 
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Fig. 2. Plasma renin activities (PRA) of sham-clipped vehicle-in- 
fused (column 1), clipped vehicle-infused (column 2), sham- 
clipped furosemide-infused (column 3) and clipped furosemide- 
infused (column 4) rats. Data are means +- SEM of five animals 
in each experimental group. * P < 0.05 ; ANG I, angiotensin I 
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Fig. 1. A Systolic blood pressure of rats before setting of the in- 
fusion pumps (day 0), before sham operation (day 4) and 48 h after 
sham operation (day 6) during vehicle and furosemide infusion. B 
Systolic blood pressure of rats before setting of the infusion pumps 
(day 0), before application of the left renal artery clip (day 4) and 
48 h after application of the clip (day 6). Data are means - SEM 
of five animals in each experimental group. * P < 0.05 versus 
day 4 
mm clips led to an increase of systolic pressure to about 
150 mm Hg (20 kPa) after 2 days both in vehicle- and in 
furosemide-infused animals (Fig. 1, lower panel). 
Furosemide infusion markedly increased PRA from 
10 to 47 ng angiotensin I h -1 m1-1 (Fig. 2). 
Unilateral renal artery clipping increased PRA va- 
lues to 37 ng angiotensin h -1 m1-1 in vehicle-infused rats 
but did not further elevate PRA values (45 ng angioten- 
sin h 1 ml-~) in furosemide-treated animals (Fig. 2). 
Renin mRNA levels in the kidneys were analysed 
by RNase protection. RNase protection assays for renin 
mRNA in total RNA were performed using a 296 base 
pair antisense riboprobe of rat preprorenin mRNA. Fig- 
ure 3 shows a representative autoradiograph of such a 
renin RNase protection assay for t tal RNA from the left 
and right kidneys isolated from a nonclipped vehicle- 
infused, left-side clipped vehicle-infused, a nonclipped 
furosemide-infused and a left-side clipped furosemide- 
Fig. 3. Autoradiograph of RNase protection assay forrenin mRNA 
with total renal RNA isolated from a vehicle-infused sham-clipped 
(Control), vehicle-infused clipped (clip), furosemide-infused 
sham-clipped and furosemide-infused clipped rat. 20 gg of total
RNA were analysed in each assay. R, Right (contralateral) kidney; 
L, left (clipped) kidney; St., 20 gg of RNA 
infused rat. For comparison and quantification 20 gg of 
an aliquot from a pool of total RNA isolated from 12 
kidneys of 6 normal adult male rats was coanalysed on 
the gel as an external standard (St). It is evident from 
Fig. 3 that renin mRNA was increased in the kidneys 
from the furosemide-infused nonclipped rat when com- 
pared with the nonclipped vehicle-infused animal. Left 
renal artery clipping led to a marked increase of renin 
mRNA in the clipped kidney and to a suppression of 
renin mRNA in the contralateral kidney of vehicle-in- 
fused rats. In the furosemide-infused animals clipping 
led to a further increase of renin mRNA in the ipsilateral 
kidney and to a somewhat attenuated suppression in the 
contralateral kidneys. For further quantification pro- 
tected fragments were excised from the dried gels and 
measured by t-counting. After background subtraction 
the radioactivity of each band was related to that of the 
external standard RNA and expressed as percentage of 
the standard. Average renin mRNA levels that were 
quantified in this way for left and right kidneys isolated 
from the rats of the four experimental groups are sum- 
marized in Fig. 4. 
In nonclipped animals there was no systematic side 
difference of renin mRNA levels between the two kid- 
neys and furosemide infusion led to a 2.5-fold increase 
of basal renin mRNA levels (Fig. 4). In vehicle-infused 
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Fig. 4. Upper panel shows renal renin mRNA levels expressed in
relation to an external standard in sham-clipped vehicle-infused 
and clipped vehicle-infused rats. Lower panel shows renal renin 
mRNA levels expressed in relation to an external standard in 
sham-clipped furosemide-infused and clipped furosemide-infused 
rats. Data are means + SEM of five animals in each experimental 
group * P < 0.05. R, Right (contralateral) kidney; L, left (clipped) 
kidney 
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Fig. 5. Upper panel shows renal actin mRNA levels expressed in
relation to an external standard in sham-clipped vehicle-infused 
and clipped vehicle-infused rats. Lower panel shows renal actin 
mRNA levels expressed in relation to an external standard in 
sham-clipped furosemide-infused and clipped furosemide-infused 
rats. Data are means + SEM of five animals in each experimental 
group. * P < 0.05, R, right (contralateral) kidney; L, left (clipped) 
kidney 
rats clipping of the left renal artery with a 0.2-mm clip 
increased renin mRNA levels to the 5-fold value of the 
basal level in the clipped kidney and decreased mRNA 
levels to 16% of the basal level in the contralateral fight 
kidneys (Fig. 4). In furosemide-infused animals renin 
mRNA levels rose to similar absolute levels as in ve- 
hicle-infused rats in the clipped kidneys and decreased 
to 20% of the respective basal value in the contralateral 
kidneys. 
For control we also analysed the expression of a 
house-keeping gene such as fl-actin in vehicle- and furo- 
semide-treated rats. As shown in Fig. 5 there was a ten- 
dency towards higher actin mRNA levels in the clipped 
kidneys of both vehicle- and furosemide-infused ani- 
mals. There was, however, no difference of actin mRNA 
levels between vehicle- and furosemide-infused rats. 
Discussion 
This study was done to examine a possible involvement 
of the macula densa mechanism in the regulation of re- 
nal renin gene expression in 2-kidney/i-clip rats. 
To inhibit thick ascending limb and macula densa 
transport function we used the loop diuretic furosemide, 
which was effective as indicated by the high urine flow 
rates. A relevant side effect of furosemide with regard 
to the renin system is a volume contraction induced by 
the marked loss of salt and water [23]. To avoid such a 
volume contraction the animals were allowed to have 
free access to salt and water. This regimen in fact pre- 
vented decreases of plasma sodium concentration and 
of blood pressure during furosemide treatment (Table 1, 
Fig. 1). These observations are thus in good accordance 
with the recent demonstration that free access to salt and 
water maintains normal sodium balance and blood pres- 
sure in adrenalectomized, hormone-supplemented rats 
during chronic furosemide infusion [8]. It appears 
reasonable to assume therefore that the observed effects 
of furosemide on renin secretion and renin gene ex- 
pression were due to a more specific renal effect of the 
drug rather than to a side effect such as volume contrac- 
tion, sodium depletion or a fall of blood pressure. 
The observation that furosemide increased PRA va- 
lues and renin mRNA levels is in keeping with several 
previous papers [1, 3, 6, 12, 14] and suggests that inhi- 
bition of salt transport by the thick ascending limb of 
Henl6, including the macula densa, stimulates both renin 
secretion and renin gene expression. Moreover, we have 
recently provided evidence that inhibition of macula 
densa salt transport leads to a recruitment of renin pro- 
ducing cells in the kidneys [14]. The observation that 
clipping of one renal artery increased renin secretion as 
indicated by the elevated PRA values confirms previous 
in vivo and in vitro reports [15, 17]. Also the increase 
of renin mRNA levels in the ipsilateral kidneys and the 
suppression of renin mRNA levels in the contralateral 
kidneys is in accordance with results obtained by others 
[13, 15, 19] and ourselves [5]. Our findings now show 
that furosemide treatment did not further increase sys- 
temic PRA values, nor renin mRNA levels in the ipsilat- 
eral clipped kidneys whilst there again occurred a 
marked suppression of renin mRNA levels in the contra- 
lateral kidneys. 
These findings do indicate that the stimulations of 
renin gene expression by low perfusion pressure and by 
inhibition of the macula densa salt transport are not addi- 
tive and could suggest herefore that they share a com- 
mon pathway. It may be argued that clipping of the renal 
arteries had already caused a maximal stimulation of re- 
nin gene expression, thus precluding any additive effect 
of furosemide. It has, however, been demonstrated re- 
cently that furosemide treatment in combination with a 
low salt diet led to a 13-fold increase of renal renin 
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mRNA levels in conscious rats [12], indicating that renin 
gene expression had not reached its upper limit in the 
clipped kidneys in our study. Thus our results would be 
compatible with the idea that the macula densa mecha- 
nism contributes to the pressure control of renin gene 
expression. 
In the contraletaral kidneys furosemide treatment did 
not prevent the suppression of renin gene expression, 
where renin mRNA levels decreased in proportion, as in 
vehicle-infused animals. This suggests that the macula 
densa mechanism is not essentially involved in this pro- 
cess. 
The mechanisms leading to suppression of renin 
gene expression in contralaterals to stenosed kidneys 
have not yet been unequivocally elucidated. It is specu- 
lated that an enhanced systemic generation of angioten- 
sin II, which is a well known suppressor of renin gene 
expression [7, 10, 16, 21], due to increased release of 
renin from the stenosed kidney, is causally involved in 
this process [17]. It should be of interest in this context 
that contralateral suppression of renin gene expression 
occurred also in furosemide-infused animals, in which 
PRA values did not further increase upon renal artery 
clipping. This may indicate that the enhancement of sys- 
temic renin activity is not the only mechanism by which 
unilateral renal artery stenosis leads to contralateral sup- 
pression of renin mRNA levels. Similarly, clipping of 
unilateral renal artery led to a significant increase of 
blood pressure in furosemide-infused animals, although 
PRA values did not increase further. In consequence one 
could speculate about the existence of a second factor 
which is released from hypoperfused kidneys and that 
acts in combination with an increased systemic renin ac- 
tivity to cause hypertension and contralateral suppres- 
sion of renin gene expression. 
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